IHS Chemical Week

EnviroTech :: R&D

Lonza Signs Deal with Swedish Start-up

4:26 AM MDT | March 17, 2011 | Alex Scott

Lonza says it has signed a deal to provide development and cGMP manufacturing services for Athera (Solna, Sweden), a start-up biotech company. Financial terms were not disclosed. Athera is part of Karolinska Development (Solna), a group which has a portfolio of more than 40 pharmaceutical companies.   Lonza says it will initiate cell line and process development, using its GS Gene expression system for Athera’s monoclonal antibody, PC-mAb, a developmental drug intended for the treatment of patients with acute coronary syndrome (ACS). People with ACS...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa